trending Market Intelligence /marketintelligence/en/news-insights/trending/3yfcv4zptp7mdbzwetqmmg2 content esgSubNav
In This List

Aratana Therapeutics director resigns; adds 2 board members

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Aratana Therapeutics director resigns; adds 2 board members

Aratana Therapeutics Inc. said Rip Gerber resigned from its board, and announced the appointment of Craig Barbarosh and Lowell Robinson as directors.

Engaged Capital LLC, which owns 5.2% of the Kansas-based pet therapeutics company, nominated the board members in April.

Barbarosh is a director and vice chairman at Quality Systems Inc. He is also a Sabra Health Care REIT Inc. board member.

Robinson is the former CFO, COO and chief administrative officer of MIVA Inc.